NCT01325337 - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia | Biotech Hunter

Enrollment

307

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions

AlopeciaAlopecia, AndrogeneticBaldness

Interventions

DRUG

bimatoprost Formulation A

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost Formulation B

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost Formulation C

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost vehicle solution

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

minoxidil 5% solution

Approximately one mL dose applied evenly onto pre-specified area on scalp, twice daily for 6 months.

Trial Locations (2)

Portland

Berlin